We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
Your Password has changed! Please login again
Cart
Outdated Browser Detected
Our website has detected that you are using an outdated browser that will prevent you from accessing certain features.
Please use one of the below recommended browsers to improve your browsing experience
Working at West means being part of a culture of giving and working by the side of the communities where we operate. Our team members are passionate about making a difference and donate considerable time and resources through our corporate giving and volunteer programs. West’s giving strategy focuses on three elements: corporate giving through direct charitable gifts made by West Pharmaceutical Services, Inc., scholarships and matching gifts awarded through the Herman O. West Foundation, an independently managed 501(c)(3) entity and our team member-led giving program, West without Borders*.
West without Borders builds upon our culture of giving back to the communities in which we live and work. West team members regularly come together to give back to the local community. WestGives, our online portal, also offers team members the ability to search for volunteer opportunities in their community and track volunteer hours for West-sponsored events.
For many years, West has targeted its philanthropic efforts to support charities focused on children, people with disabilities, healthcare and education, with a focus on STEM (Science, Technology, Engineering and Math). Since the inception of West without Borders in 2004, team members at West’s 27 sites have raised and donated more than $3 million dollars for a variety of charities around the world.
“We have a strong culture of giving back at West. Across all our sites, team members work together to support charities that have special meaning to them in their local communities. We are proud of how many of our team members support these important initiatives, and the impact we are making across the globe,” shared Emily Denney, VP Global Communications and Corporate Philanthropy.
This year, our commitment to giving back was evident through the impressive 65,969 pounds of food that was collected in just two weeks during our fourth annual Global Food Drive. That’s an impressive 9,000+ pounds more than we gathered last year to donate to local charities and food banks! To date, we’ve collected and distributed 191,693 pounds globally in our first four years.
The food gathered during this drive was donated to more than 40 charities and food banks around the world to fight hunger by helping those in need. Some recipients of our donations included:
St. Mary’s Food Bank Alliance, United States
Singapore Children’s Society, Singapore
The Salvation Army, United States
Eschweiler Tafel, Germany
Waterford Food Bank, Ireland
For more information about West and our culture of giving, please visit the Our Culture of Giving page on our website.
#WestByYourSide #WhyJoinWest
West without Borders is not affiliated with Doctors Without Borders®, which is a registered service mark of Bureau International de Médecins San Frontières.
Compendial documents developed by both international and national organizations outline specifications for elastomeric components that are used in packaging of parenteral drug products. These specifications often are not harmonized; not all compendia specify the use of the same tests, and some tests that are used globally have varying specifications. Understanding these specifications and how they influence packaging/delivery of parenteral drug products in global markets is critical.
The regulatory landscape in China continues to evolve and become more stringent. In December 2018, the Chinese Pharmacopoeia Commission (ChPC) published: Second Draft for Comments on Guideline for Stability Study of Plastic and Rubber Pharmaceutical Packaging Materials. This guideline comprises part of the results of a research project organized by ChPC in 2016 and is one of the actions taken by National Drug Administration of China (formerly the China Food and Drug Administration, CFDA) to support the previously announced Opinions on Reforming the Review and Approval System for Drugs and Medical Devices (No. 44).
I’ve worked at West for 28 years. I lead our Venture Group, Global Labs, and Data Science Team; I’ve spent most of my career in R&D. There’s an expectation from our customers that West will lead the way in developing new products. Ones that are going to be better for patients, easier to use and more cost efficient for the health system. That expectation drives a lot of the R&D work we do.
Scott Young
VP, R&D, Labs, Venture and Ext Collaboration Engineering
As of 2018, over 4,000 new injectable drug products are in development world wide – a great many of these in small settings such as universities, medical research institutes, and small companies. These efforts need the ready availability of high quality, sterile packaging products in small volumes for developmental and clinical phases.
On March 26, the Delaware Valley Chapter of PDA and West Pharmaceutical Services, Inc. co-sponsored a workshop: Defining a Strategy for Combination Products, at West’s headquarters in Exton, PA. More than 150 people from 45 companies that provide drug products and combination products attended. In prior PDA events, combination product regulatory challenges have been cited often as an area both of interest and confusion. This workshop aimed to address them.